These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33925806)

  • 1. Development of a High-Throughput Method to Study the Inhibitory Effect of Phytochemicals on Trimethylamine Formation.
    Iglesias-Carres L; Essenmacher LA; Racine KC; Neilson AP
    Nutrients; 2021 Apr; 13(5):. PubMed ID: 33925806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential of Phenolic Compounds and Their Gut Microbiota-Derived Metabolites to Reduce TMA Formation: Application of an
    Iglesias-Carres L; Krueger ES; Herring JA; Tessem JS; Neilson AP
    J Agric Food Chem; 2022 Mar; 70(10):3207-3218. PubMed ID: 35235743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenolic-rich beverages reduce bacterial TMA formation in an
    Iglesias-Carres L; Racine KC; Neilson AP
    Food Funct; 2022 Aug; 13(15):8022-8037. PubMed ID: 35839103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary phenolics and their microbial metabolites are poor inhibitors of trimethylamine oxidation to trimethylamine N-oxide by hepatic flavin monooxygenase 3.
    Iglesias-Carres L; Chadwick-Corbin SA; Sweet MG; Neilson AP
    J Nutr Biochem; 2023 Oct; 120():109428. PubMed ID: 37549832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary Methionine Restriction Alleviates Choline-Induced Tri-Methylamine-N-Oxide (TMAO) Elevation by Manipulating Gut Microbiota in Mice.
    Lu M; Yang Y; Xu Y; Wang X; Li B; Le G; Xie Y
    Nutrients; 2023 Jan; 15(1):. PubMed ID: 36615863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of an in-vitro batch fermentation (human colon) model for investigating mechanisms of TMA production from choline, L-carnitine and related precursors by the human gut microbiota.
    Day-Walsh P; Shehata E; Saha S; Savva GM; Nemeckova B; Speranza J; Kellingray L; Narbad A; Kroon PA
    Eur J Nutr; 2021 Oct; 60(7):3987-3999. PubMed ID: 33934200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis.
    Wang Z; Roberts AB; Buffa JA; Levison BS; Zhu W; Org E; Gu X; Huang Y; Zamanian-Daryoush M; Culley MK; DiDonato AJ; Fu X; Hazen JE; Krajcik D; DiDonato JA; Lusis AJ; Hazen SL
    Cell; 2015 Dec; 163(7):1585-95. PubMed ID: 26687352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide.
    Romano KA; Vivas EI; Amador-Noguez D; Rey FE
    mBio; 2015 Mar; 6(2):e02481. PubMed ID: 25784704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of intestinal microbiota-dependent production of pro-atherogenic trimethylamine N-oxide by shifting L-carnitine microbial degradation.
    Kuka J; Liepinsh E; Makrecka-Kuka M; Liepins J; Cirule H; Gustina D; Loza E; Zharkova-Malkova O; Grinberga S; Pugovics O; Dambrova M
    Life Sci; 2014 Nov; 117(2):84-92. PubMed ID: 25301199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic retroconversion of trimethylamine N-oxide and the gut microbiota.
    Hoyles L; Jiménez-Pranteda ML; Chilloux J; Brial F; Myridakis A; Aranias T; Magnan C; Gibson GR; Sanderson JD; Nicholson JK; Gauguier D; McCartney AL; Dumas ME
    Microbiome; 2018 Apr; 6(1):73. PubMed ID: 29678198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An in vitro exploratory study of dietary strategies based on polyphenol-rich beverages, fruit juices and oils to control trimethylamine production in the colon.
    Bresciani L; Dall'Asta M; Favari C; Calani L; Del Rio D; Brighenti F
    Food Funct; 2018 Dec; 9(12):6470-6483. PubMed ID: 30465688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small molecule inhibition of gut microbial choline trimethylamine lyase activity alters host cholesterol and bile acid metabolism.
    Pathak P; Helsley RN; Brown AL; Buffa JA; Choucair I; Nemet I; Gogonea CB; Gogonea V; Wang Z; Garcia-Garcia JC; Cai L; Temel R; Sangwan N; Hazen SL; Brown JM
    Am J Physiol Heart Circ Physiol; 2020 Jun; 318(6):H1474-H1486. PubMed ID: 32330092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Berberine attenuates choline-induced atherosclerosis by inhibiting trimethylamine and trimethylamine-N-oxide production via manipulating the gut microbiome.
    Li X; Su C; Jiang Z; Yang Y; Zhang Y; Yang M; Zhang X; Du Y; Zhang J; Wang L; Jiang J; Hong B
    NPJ Biofilms Microbiomes; 2021 Apr; 7(1):36. PubMed ID: 33863898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blueberry intervention mitigates detrimental microbial metabolite trimethylamine N-oxide by modulating gut microbes.
    Satheesh Babu AK; Petersen C; Iglesias-Carres L; Paz HA; Wankhade UD; Neilson AP; Anandh Babu PV
    Biofactors; 2024; 50(2):392-404. PubMed ID: 37921575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary TMAO Levels Are Associated with the Taxonomic Composition of the Gut Microbiota and with the Choline TMA-Lyase Gene (
    Dalla Via A; Gargari G; Taverniti V; Rondini G; Velardi I; Gambaro V; Visconti GL; De Vitis V; Gardana C; Ragg E; Pinto A; Riso P; Guglielmetti S
    Nutrients; 2019 Dec; 12(1):. PubMed ID: 31881690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous determination of choline, L-carnitine, betaine, trimethylamine, trimethylamine N-oxide, and creatinine in plasma, liver, and feces of hyperlipidemic rats by UHPLC-MS/MS.
    Xu C; Zhang M; Zhang S; Wang P; Lai C; Meng D; Chen Z; Yi X; Gao X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Aug; 1243():124210. PubMed ID: 38936270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of choline-degrading bacteria from healthy human feces and used for screening of trimethylamine (TMA)-lyase inhibitors.
    Heng X; Liu W; Chu W
    Microb Pathog; 2021 Mar; 152():104658. PubMed ID: 33253857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of dietary phytochemicals for inhibition of trimethylamine N-oxide formation.
    Iglesias-Carres L; Hughes MD; Steele CN; Ponder MA; Davy KP; Neilson AP
    J Nutr Biochem; 2021 May; 91():108600. PubMed ID: 33577949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted Inhibition of Gut Microbial Trimethylamine N-Oxide Production Reduces Renal Tubulointerstitial Fibrosis and Functional Impairment in a Murine Model of Chronic Kidney Disease.
    Gupta N; Buffa JA; Roberts AB; Sangwan N; Skye SM; Li L; Ho KJ; Varga J; DiDonato JA; Tang WHW; Hazen SL
    Arterioscler Thromb Vasc Biol; 2020 May; 40(5):1239-1255. PubMed ID: 32212854
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Qiu L; Yang D; Tao X; Yu J; Xiong H; Wei H
    J Microbiol Biotechnol; 2017 Aug; 27(8):1491-1499. PubMed ID: 28511293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.